Trade Summary

6 days ago, Barber Daniel, serving as President and CEO at Aquestive Therapeutics, Inc. (AQST), sold 25,000 shares at $4.01 per share, for a total transaction value of $100,191.90. Following this transaction, Barber Daniel now holds 610,574 shares of AQST.

This sale represents a 3.93% decrease in Barber Daniel's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, July 15, 2026 and publicly disclosed via SEC Form 4 filing on Friday, July 17, 2026 at 1:15 PM ET, 2 days after the trade was made.

Aquestive Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.